NEW YORK--(BUSINESS WIRE)--AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new analysis from Michigan's largest health system provides sobering verification of the risks ...
Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. Patients with a dangerously prolonged QTc are at increased risk for ...
ROCHESTER, Minn. - SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 ...
The Rapid Growth of Remote Patient Monitoring Solutions Can Accelerate Decentralized Clinical Trials
Pharma companies and RPM manufacturers must work together to find solutions to make DCT more commonly available. For years, the pharmaceutical industry has known that decentralized trials, in which ...
Tyrosine kinase inhibitors (TKIs) are associated with prolongation of the QTc interval on the electrocardiogram (ECG). The QTc-interval prolongation increases the risk of life-threatening arrhythmias.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results